Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Ezetimibe + Simvastatin 10 mg/40 mg versus Vytorin in healthy Thai volunteers under fasting
TCTR20210323002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- May 2021
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Vytorin in hypercholesterolemia (2 arms), sponsored by Bio-innova. Planned start May 2021; status: not yet recruiting.
02
Drugs
Vytorin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on TCTR20210323002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210323002.